- US-listed companies
- Akari Therapeutics Plc
- Balance sheet
Akari Therapeutics Plc (AKTX) Balance sheet
Market cap
$530.2B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | 8 | 6 | 69 | 34 | 28 | 6 | 6 | 14 | 9 | 13 | 4 | 3 | 5 |
| Total cash & short-term investments | 8 | 6 | 69 | 34 | 28 | 6 | 6 | 14 | 9 | 13 | 4 | 3 | 5 |
| Total current assets | 8 | 6 | 70 | 46 | 29 | 7 | 7 | 15 | 12 | 14 | 4 | 3 | 5 |
| Property, plant and equipment, net | - | 0 | 40,513 | 58,364 | 55,898 | 20,425 | 5,013 | - | - | - | - | - | - |
| Total assets | 8 | 6 | 70 | 46 | 29 | 8 | 7 | 15 | 12 | 14 | 4 | 51 | 48 |
| Accounts payable | - | - | 4 | 2 | 2 | 2 | 1 | 3 | 2 | 946,658 | 2 | 12 | 9 |
| Total current liabilities | 1 | 1 | 21 | 12 | 12 | 5 | - | - | - | - | - | 20 | 12 |
| Total non-current liabilities | 1 | 0 | 49,069 | 56,360 | 48,003 | - | - | - | - | - | - | - | - |
| Total liabilities | - | - | 21 | 12 | 12 | 5 | 9 | 5 | 6 | 12 | 5 | 28 | 20 |
| Retained earnings | -21 | -30 | -56,796,613 | -74,937,610 | -110,336,867 | -126,803,647 | -143,909,438 | -182,280,811 | -199,705,048 | -217,453,110 | -227 | -247 | -264 |
| Stockholders' equity | 6 | 5 | 49 | 34 | 17 | 3 | -1,772,458 | 9 | 6 | 2 | -0 | 22 | 28 |